InvestorsObserver
×
News Home

How Will the Market React to Qualigen Therapeutics Inc (QLGN) Stock Getting a Bearish Rating

Wednesday, January 19, 2022 11:14 AM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Qualigen Therapeutics Inc (QLGN) Stock Getting a Bearish Rating

Overall market sentiment has been down on Qualigen Therapeutics Inc (QLGN) stock lately. QLGN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Qualigen Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on QLGN!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With QLGN Stock Today?

Qualigen Therapeutics Inc (QLGN) stock is down -1.3% while the S&P 500 is up 0.02% as of 11:11 AM on Wednesday, Jan 19. QLGN is down -$0.01 from the previous closing price of $1.01 on volume of 324,840 shares. Over the past year the S&P 500 is higher by 20.51% while QLGN is down -70.24%. QLGN lost -$0.15 per share in the over the last 12 months.

More About Qualigen Therapeutics Inc

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Click Here to get the full Stock Report for Qualigen Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App